MQ Insider Sale: Sumner Crystal Disposes 45,500 Shares Under 10b5-1 Plan
Rhea-AI Filing Summary
Sumner Crystal, Chief Administrative Officer and Corporate Secretary of Marqeta, Inc. (MQ), reported the sale of 45,500 Class A common shares on 09/09/2025 at a weighted average price of $5.9989 per share (individual trade prices ranged from $5.96 to $6.06). After the reported transactions, the reporting person beneficially owned 282,754 shares. The filing indicates the sale was made pursuant to a written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1. The Form 4 was signed by an attorney-in-fact.
Positive
- Sale documented under a Rule 10b5-1 plan, indicating a pre-arranged trading plan intended to provide an affirmative defense
- Complete disclosure of weighted-average price range ($5.96 to $6.06) and post-transaction beneficial ownership (282,754 shares)
Negative
- Insider sale of 45,500 shares by an officer, which reduces the officers direct holdings and may be viewed as insider liquidity
- No information provided on remaining economic interest beyond beneficially owned share count (e.g., no detail on other indirect holdings or option positions)
Insights
TL;DR: Officer sold 45,500 MQ shares under a 10b5-1 plan; remaining stake 282,754 shares.
The sale of 45,500 Class A shares represents a material disposition by an officer but is documented as executed under a 10b5-1 plan, which generally provides pre-arranged sale scheduling and an affirmative defense for trading while in possession of material nonpublic information. The weighted average price was $5.9989 with trades between $5.96 and $6.06, and the filing reports the post-transaction beneficial ownership as 282,754 shares. No other transactions or derivative positions are reported. This is a straightforward insider liquidity event with disclosure consistent with Section 16 requirements.
TL;DR: Transaction follows a Rule 10b5-1 plan and was certified by counsel; disclosure appears complete.
The checkbox indicating the transaction was made pursuant to a contract or written plan (Rule 10b5-1) and the explanatory footnote about weighted average pricing support compliance with disclosure norms. The form identifies the reporting persons role and shows an attorney-in-fact executed the filing. There are no indications in the filing of amendments, derivative transactions, or other arrangements. From a governance perspective, the reporting and documentation meet standard Section 16 disclosure expectations.